Investigating new treatments for infectious diseases through clinical trials.
Official title: Early Phase Clinical Trial Units (EPCTU)
Funded at Allucent Government Services (Us) LLC · NIH-11259399 · Data updated 2026-11-12
This study is looking for people to try out new treatments for infectious diseases that aren't available yet, so if you join, you'll get to help test these therapies while being closely watched for safety and effectiveness.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Allucent Government Services (Us) LLC NIH-funded |
| Lab location | 1 site (Cary, United States) |
| Project start | January 14, 2022 |
| Project end | January 13, 2026 |
| Funding year | 2025 |
| Award (this year) | $143,797 |
| NIH project number | 75N93022D00015-P00003-759302200001-1 |
| Project ID | NIH-11259399 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation are individuals diagnosed with infectious diseases who are seeking new treatment options.
✕Less likely to help
Patients with non-infectious diseases or those who do not meet the specific criteria for the trials may not benefit from this research.
What this research studies
The Early Phase Clinical Trial Units focus on testing new agents aimed at treating and preventing infectious diseases. This research involves implementing interventional clinical trials, which means that patients may receive new therapies that are not yet widely available. Participants will be closely monitored throughout the trial to assess the effectiveness and safety of these new treatments. The goal is to gather valuable data that can lead to improved options for managing infectious diseases.
Why it matters
Potential benefit: If successful, this research could lead to new and effective treatments for infectious diseases, improving patient outcomes.
How similar studies have gone: Previous research has shown success in similar early phase clinical trials, indicating a promising approach to developing new therapies.
Where this research is happening
-
Allucent Government Services (Us) LLC
Cary, United States Active
Researchers
- Principal investigator: Mckee, Kelly — Allucent Government Services (Us) LLC
- Study coordinator: Mckee, Kelly
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.